Clinical Study

Pycnogenol® May Reduce Severity and Frequency of Migraine Symptoms

Format: PDF file | Document type: Clinical Study | Promoted Content

This Clinical Study has been written by Horphag Research, and any views and opinions expressed do not necessarily reflect those of www.nutraingredients-usa.com

Pycnogenol® May Reduce Severity and Frequency of Migraine Symptoms

Newly published research on Pycnogenol®​, French maritime pine bark extract showed a 61% decreased frequency of migraine attacks, 39% easing of migraine-induced discomfort, and 41% reduction in affected daily activities due to migraines.

Related resources from Horphag Research

Show more

Supplier info centre